Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending November 24, 2019 Ixekizumab Effective Over Long Term For Psoriasis, Umeclidinium/Vilanterol Outperforms Rivals in Low-Risk COPD, Revefenacin Maintains Benefits Over 52 weeks, Biomarkers Point to Better Azithromycin Performance in COPD, Benefits of BGF Triple Fixed-Dose Therapy Consistent in COPD Patients Without Exacerbation History, More must reads Must reads for theWeek ending November 17, 2019 Feds Propose New Price Transparency Rules in Health Care, Support For Medical Marijuana Transcends Political Affiliation, ACP Makes Recommendations to Address Rising Drug Prices, Oral Anticancer Spending in Part D Tied in Major Part to Price Increases, Drug Spending Driving up Part B Premiums and Deductibles, More must readsMust reads for theWeek ending November 10, 2019 Observational Secukinumab Data Reflect Clinical Trial Results in Patients With Moderate to Severe Psoriasis, Clinician Burnout Can Impact Quality of Care, Training, Alerts Up The Odds of Discussions About Genomic Testing Costs, MIPS, E/M Changes Highlight 2020 Medicare Fee Schedule, Demeaning Patient Behavior Takes Emotional Toll on Physicians, More must readsMust reads for theWeek ending November 3, 2019 Psoriasis Registry Data Provide Evidence That Adalimumab Reduces Mortality, PASI-75 With Ixekizumab Approaches 90% in Pediatric Psoriasis Study, Corticosteroid Use in Pregnancy Linked to Preterm Birth, More must readsMust reads for theWeek ending October 27, 2019 Mindfulness-Based Cognitive Therapy Lowers Rumination in Patients With Depression, Insulin Resistance Associated With Depression , White Matter Damage Higher in Older Adults With Depression , Genes Involved in Depression Symptomatology Identified in Twin Study , High Cortisol, Inflammation Tied to Persistent Depressive Symptoms, More must readsPages1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 next › last »
